31-05-2023 21:15:43 | Current | EBI | 7/2023
The Management Board of Mycodern S.A., headquartered in Gdansk, in reference to the current report EBI No. 1/2023 dated January 31, 2023, in which it provided the schedule for the publication of periodic reports in 2023, hereby informs that it has changed the publication date of the annual separate and consolidated reports for 2022 and set a new date for their publication as June 7, 2023.
At the same time, the Management Board informs that it is in violation of its disclosure obligations due to the failure to submit the annual reports of the separate and consolidated for 2022 by the end of the 5th month after the balance sheet date (i.e., by May 31, 2023), and due to the failure to submit this report to change the publication date of these annual reports for 2022 at least 2 days before the previously announced date of their publication, which was today.
The Board of Directors informs that the change of the publication date of the separate and consolidated annual reports for 2022 is due to the prolonged work on the preparation of these reports.
Legal basis:
– § 6 section 14.2 of Appendix No. 3 to the Regulations of the Alternative Trading System “Current and periodic information provided in the alternative trading system on the NewConnect market”,
– Section 16a of Appendix No. 1 to Resolution No. 795/2008 of the Warsaw Stock Exchange Management Board dated October 31, 2008. “Good practices of companies listed on NewConnect” (as amended by Resolution No. 293/2010 of the Management Board of the Warsaw Stock Exchange SA of March 31, 2010 on the amendment of the document “Good practices of companies listed on NewConnect”).
- Piotr Zawadzki – President of the Management Board
2023. Mycodern S.A.